![[S(R)]-N-[(R)-[2-(二苯基膦基)苯基] -1-萘甲基] -N,2-二甲基-2-丙烷亚磺酰胺,95％ [S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]-1-naphthalenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%](https://img.nicebiochem.com/20250502/89f20c8981610e19156414693f4e35e9bbcfb53340c3e8864505e2df67fc248b.png)
[S(R)]-N-[(R)-[2-(二苯基膦基)苯基] -1-萘甲基] -N,2-二甲基-2-丙烷亚磺酰胺,95％ [S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]-1-naphthalenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%
-
[S(R)]-N-[(S)-[2-(二苯基膦基)苯基] -1-萘甲基] -N,2-二甲基-2-丙烷亚磺酰胺,95％ [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]-1-naphthalenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%
ZMR-15-8340 | 50mg
-
[S(R)]-N-[(R)-[2-(二苯基膦基)苯基] -1-萘甲基] -2-甲基-2-丙烷亚磺酰胺,95％ [S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]-1-naphthalenylmethyl]-2-methyl-2-propanesulfinamide, 95%
ZMR-15-8324 | 100mg
-
[S(R)]-N-[(R)-[2-(二苯基膦基)苯基]苯基甲基] -N,2-二甲基-2-丙烷亚磺酰胺,95％ [S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%
ZMR-15-8334 | 50mg
-
[S(R)]-N-[(R)-[2-(二环己基膦基)苯基] -2-萘甲基] -N,2-二甲基-2-丙烷亚磺酰胺,95％ [S(R)]-N-[(R)-[2-(Dicyclohexylphosphino)phenyl]-2-naphthalenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%
ZMR-15-8444 | 50mg
-
[S(R)]-N-[(S)-[2-(二苯基膦基)苯基] -1-萘甲基] -2-甲基-2-丙烷亚磺酰胺,95％ [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]-1-naphthalenylmethyl]-2-methyl-2-propanesulfinamide, 95%
ZMR-15-8322 | 100mg
-
[S(R)]-N-[(R)-[2-(二环己基膦基)苯基] -2-萘甲基] -2-二甲基-2-丙烷亚磺酰胺,95％ [S(R)]-N-[(R)-[2-(Dicyclohexylphosphino)phenyl]-2-naphthalenylmethyl]-2-dimethyl-2-propanesulfinamide, 95%
ZMR-15-8446 | 50mg
-
[S(R)]-N-[(S)-[2-(二苯基膦基)苯基]苯基甲基] -N,2-二甲基-2-丙烷亚磺酰胺,95％ [S(R)]-N-[(S)-[2-(Diphenylphosphino)phenyl]phenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%
ZMR-15-8332 | 50mg
中文名称：[S(R)]-N-[(R)-[2-(二苯基膦基)苯基] -1-萘甲基] -N,2-二甲基-2-丙烷亚磺酰胺,95％
英文名称：[S(R)]-N-[(R)-[2-(Diphenylphosphino)phenyl]-1-naphthalenylmethyl]-N,2-dimethyl-2-propanesulfinamide, 95%
分子式：C34H34NOPS；分子量：535.7。
您正在浏览的产品：[S(R)]-N-[(R)-[2-(二苯基膦基)苯基] -1-萘甲基] -N,2-二甲基-2-丙烷亚磺酰胺,95％
手机版：[S(R)]-N-[(R)-[2-(二苯基膦基)苯基] -1-萘甲基] -N,2-二甲基-2-丙烷亚磺酰胺,95％
本公司销售的所有产品仅供实验科研使用，不用于人体及临床诊断。
2. 色谱条件优化：调整流动相比例使目标峰与杂质峰分离度≥1.5
以上信息仅供参考，请以相应标准的原文为准！